Introduction:
Novo Nordisk univels plans for the construction and expansion of its current facility. The expansion of the existing manufacturing facility will be located in Kalundborg, Denmark.
Features:
The project includes construction of three new manufacturing facilities and expansion of one existing facility.
The state-of-the-art productionfacility will be automated with advanced technologies.
The new construction featured with additional capacitywill support the vast global value chain in manufacturing of active pharmaceutical ingredients (API) to assembly and packaging.
The expansion benefits the additional capacity for the production of existing and future oral and injectable products.In addition, this investment will increase the manufacturing setup.
The project is expected to be completed by 2027. The new production facility is anticipated tocreate around 400 new jobs and more than 2,500 external jobs during the construction phase.
Specifications:
| Name | Novo Nordisk |
| Type | Expansion & Construction |
| Budget | US$2.32 billion (DKK 17 bn) |
